These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 33660319)

  • 1. A top scoring pairs classifier for recent HIV infections.
    Chen A; Laeyendecker O; Eshleman SH; Monaco DR; Kammers K; Larman HB; Ruczinski I
    Stat Med; 2021 May; 40(11):2604-2612. PubMed ID: 33660319
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Performance of a limiting-antigen avidity enzyme immunoassay for cross-sectional estimation of HIV incidence in the United States.
    Konikoff J; Brookmeyer R; Longosz AF; Cousins MM; Celum C; Buchbinder SP; Seage GR; Kirk GD; Moore RD; Mehta SH; Margolick JB; Brown J; Mayer KH; Koblin BA; Justman JE; Hodder SL; Quinn TC; Eshleman SH; Laeyendecker O
    PLoS One; 2013; 8(12):e82772. PubMed ID: 24386116
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of multi-assay algorithms for cross-sectional HIV incidence estimation in settings with universal antiretroviral treatment.
    Grant-McAuley W; Laeyendecker O; Monaco D; Chen A; Hudelson SE; Klock E; Brookmeyer R; Morrison D; Piwowar-Manning E; Morrison CS; Hayes R; Ayles H; Bock P; Kosloff B; Shanaube K; Mandla N; van Deventer A; Ruczinski I; Kammers K; Larman HB; Eshleman SH
    BMC Infect Dis; 2022 Nov; 22(1):838. PubMed ID: 36368950
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of two measures of HIV diversity in multi-assay algorithms for HIV incidence estimation.
    Cousins MM; Konikoff J; Sabin D; Khaki L; Longosz AF; Laeyendecker O; Celum C; Buchbinder SP; Seage GR; Kirk GD; Moore RD; Mehta SH; Margolick JB; Brown J; Mayer KH; Kobin BA; Wheeler D; Justman JE; Hodder SL; Quinn TC; Brookmeyer R; Eshleman SH
    PLoS One; 2014; 9(6):e101043. PubMed ID: 24968135
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and Evaluation of a Modified Fourth-Generation Human Immunodeficiency Virus Enzyme Immunoassay for Cross-Sectional Incidence Estimation in Clade B Populations.
    Kirkpatrick AR; Patel EU; Celum CL; Moore RD; Blankson JN; Mehta SH; Kirk GD; Margolick JB; Quinn TC; Eshleman SH; Laeyendecker O
    AIDS Res Hum Retroviruses; 2016 Aug; 32(8):756-62. PubMed ID: 26988426
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification and validation of a multi-assay algorithm for cross-sectional HIV incidence estimation in populations with subtype C infection.
    Laeyendecker O; Konikoff J; Morrison DE; Brookmeyer R; Wang J; Celum C; Morrison CS; Abdool Karim Q; Pettifor AE; Eshleman SH
    J Int AIDS Soc; 2018 Feb; 21(2):. PubMed ID: 29489059
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Field Validation of Limiting-Antigen Avidity Enzyme Immunoassay to Estimate HIV-1 Incidence in Cross-Sectional Survey in Swaziland.
    Duong YT; Dobbs T; Mavengere Y; Manjengwa J; Rottinghaus E; Saito S; Bock N; Philip N; Justman J; Bicego G; Nkengasong JN; Parekh BS
    AIDS Res Hum Retroviruses; 2019 Oct; 35(10):896-905. PubMed ID: 31204867
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of multi-assay algorithms for identifying individuals with recent HIV infection: HPTN 071 (PopART).
    Grant-McAuley W; Klock E; Laeyendecker O; Piwowar-Manning E; Wilson E; Clarke W; Breaud A; Moore A; Ayles H; Kosloff B; Shanaube K; Bock P; Mandla N; van Deventer A; Fidler S; Donnell D; Hayes R; Eshleman SH;
    PLoS One; 2021; 16(12):e0258644. PubMed ID: 34919554
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improved testing of recent HIV-1 infections with the BioRad avidity assay compared to the limiting antigen avidity assay and BED Capture enzyme immunoassay: evaluation using reference sample panels from the German Seroconverter Cohort.
    Hauser A; Santos-Hoevener C; Meixenberger K; Zimmermann R; Somogyi S; Fiedler S; Hofmann A; Bartmeyer B; Jansen K; Hamouda O; Bannert N; Kuecherer C
    PLoS One; 2014; 9(6):e98038. PubMed ID: 24892795
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of recent HIV-1 infection using a new limiting-antigen avidity assay: potential for HIV-1 incidence estimates and avidity maturation studies.
    Duong YT; Qiu M; De AK; Jackson K; Dobbs T; Kim AA; Nkengasong JN; Parekh BS
    PLoS One; 2012; 7(3):e33328. PubMed ID: 22479384
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of cross-sectional HIV incidence assay results from dried blood spots and plasma.
    Schlusser KE; Pilcher C; Kallas EG; Santos BR; Deeks SG; Facente S; Keating SM; Busch MP; Murphy G; Welte A; Quinn T; Eshleman SH; Laeyendecker O
    PLoS One; 2017; 12(2):e0172283. PubMed ID: 28231277
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Specificity of four laboratory approaches for cross-sectional HIV incidence determination: analysis of samples from adults with known nonrecent HIV infection from five African countries.
    Laeyendecker O; Brookmeyer R; Mullis CE; Donnell D; Lingappa J; Celum C; Baeten JM; Campbell MS; Essex M; de Bruyn G; Farquhar C; Quinn TC; Eshleman SH;
    AIDS Res Hum Retroviruses; 2012 Oct; 28(10):1177-83. PubMed ID: 22283149
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HIV incidence determination in the United States: a multiassay approach.
    Laeyendecker O; Brookmeyer R; Cousins MM; Mullis CE; Konikoff J; Donnell D; Celum C; Buchbinder SP; Seage GR; Kirk GD; Mehta SH; Astemborski J; Jacobson LP; Margolick JB; Brown J; Quinn TC; Eshleman SH
    J Infect Dis; 2013 Jan; 207(2):232-9. PubMed ID: 23129760
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estimating False-Recent Classification for the Limiting-Antigen Avidity EIA and BED-Capture Enzyme Immunoassay in Vietnam: Implications for HIV-1 Incidence Estimates.
    Shah NS; Duong YT; Le LV; Tuan NA; Parekh BS; Ha HTT; Pham QD; Cuc CTT; Dobbs T; Tram TH; Lien TTX; Wagar N; Yang C; Martin A; Wolfe M; Hien NT; Kim AA
    AIDS Res Hum Retroviruses; 2017 Jun; 33(6):546-554. PubMed ID: 28193090
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validation of population-level HIV-1 incidence estimation by cross-sectional incidence assays in the HPTN 071 (PopART) trial.
    Klock E; Wilson E; Fernandez RE; Piwowar-Manning E; Moore A; Kosloff B; Bwalya J; Bell-Mandla N; James A; Ayles H; Bock P; Donnell D; Fidler S; Hayes R; Eshleman SH; Laeyendecker O;
    J Int AIDS Soc; 2021 Dec; 24(12):e25830. PubMed ID: 34897992
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cross-sectional estimates revealed high HIV incidence in Botswana rural communities in the era of successful ART scale-up in 2013-2015.
    Moyo S; Gaseitsiwe S; Mohammed T; Pretorius Holme M; Wang R; Kotokwe KP; Boleo C; Mupfumi L; Yankinda EK; Chakalisa U; van Widenfelt E; Gaolathe T; Mmalane MO; Dryden-Peterson S; Mine M; Lebelonyane R; Bennett K; Leidner J; Wirth KE; Tchetgen Tchetgen E; Powis K; Moore J; Clarke WA; Lockman S; Makhema JM; Essex M; Novitsky V
    PLoS One; 2018; 13(10):e0204840. PubMed ID: 30356287
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Short Communication: Assessing Estimates of HIV Incidence with a Recent Infection Testing Algorithm That Includes Viral Load Testing and Exposure to Antiretroviral Therapy.
    Kim AA; Rehle T
    AIDS Res Hum Retroviruses; 2018 Oct; 34(10):863-866. PubMed ID: 29926735
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the Performance of Three Biomarker Assays for Recent HIV Infection Using a Well-Characterized HIV-1 Subtype C Incidence Cohort.
    Gonese E; Kilmarx PH; van Schalkwyk C; Grebe E; Mutasa K; Ntozini R; Parekh B; Dobbs T; Duong Pottinger Y; Masciotra S; Owen M; Nachega JB; van Zyl G; Hargrove JW
    AIDS Res Hum Retroviruses; 2019 Jul; 35(7):615-627. PubMed ID: 30938164
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of Early Antiretroviral Treatment Initiation on Performance of Cross-Sectional Incidence Assays.
    Klock E; Mwinnya G; Eller LA; Fernandez RE; Kibuuka H; Nitayaphan S; Kosgei J; Moore RD; Robb M; Eshleman SH; Laeyendecker O
    AIDS Res Hum Retroviruses; 2020 Jul; 36(7):583-589. PubMed ID: 32295382
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estimating HIV incidence in the Akwa Ibom AIDS indicator survey (AKAIS), Nigeria using the limiting antigen avidity recency assay.
    Negedu-Momoh OR; Balogun O; Dafa I; Etuk A; Oladele EA; Adedokun O; James E; Pandey SR; Khamofu H; Badru T; Robinson J; Mastro TD; Torpey K
    J Int AIDS Soc; 2021 Feb; 24(2):e25669. PubMed ID: 33619853
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.